首页> 外文会议>Conference of the American College of Veterinary Internal Medicine >CLINICAL TRIAL FOR CANINE DEGENERATIVE MYELOPATHY: ANTISENSE OLIGONUCLEOTIDETHERAPY
【24h】

CLINICAL TRIAL FOR CANINE DEGENERATIVE MYELOPATHY: ANTISENSE OLIGONUCLEOTIDETHERAPY

机译:犬令人退行性髓病的临床试验:反义寡核苷酸化合物

获取原文

摘要

Mutations in the superoxide dismutase 1 (SOD]) gene, which encodes cytosolic Cu/Zn superoxide dismutase (SOD1), are most prevalent with the inherited form of ALS (fALS). Familial ALS (fALS) accounts for 10% of all ALS cases; the rest appear as sporadic ALS (sALS).1 Although the etiology of the more common sALS is largely unknown, symptoms and pathology associated with SOD 1-related ALS mirror those in sALS. Since the initial discovery that mutations in SOD1 could cause ALS,2 more than 160 SOD I mutations have been identified in ALS patients flittp://alsod,iop,kcl,ac,uk/'), accounting for approximately 20% of fALS cases.3 SOD1 aggregates in motor neurons are the histopathologic hallmark of SOD1 -mediated ALS.
机译:在编码细胞溶化酶1(SOD])基因中的超氧化物歧化酶1(SOD)基因的突变与遗传形式的ALS(FAL)普遍普遍。家庭ALS(FAL)占所有ALS案件的10%;其余的表现为零星ALS(SAL).1虽然更常见的含硅的病因在很大程度上是未知的,症状和病理学与SOD 1相关的ALS镜中含有含硅的症状和病理学。由于SOD1中突变可能导致ALS的初始发现,在ALS患者Flittp:// Alsod,IOP,KCL,AC,UK /')中鉴定了超过160个SOD I突变,占FALS案件的约20% .3 SOD1电机神经元的聚集体是SOD1介质的ALS的组织病理学标志。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号